A medical practice sells its data to AI by licensing de-identified patient records to a buyer like Mercor. The valuable part is years of free-text physician notes, not the structured fields.
Mercor pays medical practices and health systems $80,000 to $820,000. It wants 10 or more clinicians, or 2,500 or more patients, with 12 months of visits each.
HIPAA is the whole game here. De-identified records sit outside the Privacy Rule, while selling identifiable records needs a patient authorization that says you’re being paid.
For the full process across every industry, start with our guide to how to sell your company’s data to AI companies.
Key takeaways
- Mercor’s medical practice listing pays $80,000 to $820,000 and asks for an EHR with real physician notes, not only structured fields.
- Imaging centers and digital health companies have their own listings, at $80,000 to $620,000 and $100,000 to $900,000.
- 45 CFR 164.502(a)(5)(ii)(A) bars a covered entity from selling protected health information without an authorization under 164.508(a)(4).
- Properly de-identified records aren’t protected health information at all, so the Privacy Rule stops applying to them.
- Safe Harbor de-identification means stripping 18 categories of identifier, including every mention buried in a narrative note.
- Behavioral health records from a federally assisted substance use program carry a second rule, 42 CFR Part 2.
What medical practice data do AI companies buy?
Mercor’s medical practice listing, read November 6, 2026, splits it up like this:
| Data | Mercor’s view | Main risk |
|---|---|---|
| De-identified charts with physician notes | Core of the license | Names and dates inside free text |
| Diagnoses, medications, labs, vitals | Core of the license | Rare conditions that identify a patient |
| Imaging reports | Core of the license | Radiologist and patient names in the header |
| CPT and E&M coding with claims | Adds to what you earn | Payer contract terms |
| Specialty patients: oncology, cardiology, neurology, rare disease | Adds to what you earn | Small cohorts are easy to re-identify |
| Behavioral health and women’s health records | Adds to what you earn | 42 CFR Part 2 and state law |
| Wearable or app data linked to the same patients | Adds to what you earn | Device vendor terms |
| Synthetic or sample charts | Not a fit | Rejected outright |
Mercor names the practices it wants:
- Primary care, which it calls the most requested
- Multi-specialty groups
- Urgent care
- Behavioral health
- Women’s health
- Specialty practices, which it says are in strong demand
- Digital health platforms that hold patient records
It works with exports from Epic, athenahealth, eClinicalWorks, NextGen, Oracle Health and Elation. United States records are preferred, and other countries are considered.
The size bar is low. Ten clinicians or 2,500 patients clears it, as long as each patient has 12 months or more of visits.
How much is medical practice data worth to AI companies?
Healthcare is the only category on Mercor’s board with three separate listings. Each one pays a referrer up to $70,000.
| Mercor listing | Company earns | Size bar | What it buys |
|---|---|---|---|
| Medical Practice or Health System | $80,000 to $820,000 | 10+ clinicians or 2,500+ patients | De-identified charts with notes |
| Imaging & Diagnostics Center | $80,000 to $620,000 | Any size | Studies and waveforms with signed reports |
| Digital Health Company | $100,000 to $900,000 | 10 to 500 employees | Consented visit recordings and transcripts |
The $820,000 top end sits mid-table across Mercor’s 25 listings. Manufacturing tops the board at $1.5 million, and law firms reach $1.2 million.
Note depth beats patient count. Mercor’s first question is which EHR you use and how many patients and years it covers, and its fit list asks for free-text notes rather than structured fields alone.
Our guide to how much company data is worth to AI compares published payouts across industries.
Does HIPAA let you sell patient data to AI companies?
Two rules decide this. The first is 45 CFR 164.502(a)(5)(ii)(A), which says that “except pursuant to and in compliance with 164.508(a)(4), a covered entity or business associate may not sell protected health information.”
The second is 164.508(a)(4)(ii). An authorization for a sale “must state that the disclosure will result in remuneration to the covered entity.”
Getting thousands of patients to sign that is not a real plan. Every practical deal runs on de-identified data instead.
The relief is in 164.502(d)(2). Information de-identified under 164.514(a) and (b) “is considered not to be individually identifiable health information,” and the subpart’s requirements don’t apply to it.
The same section, 164.502(d)(1), lets you disclose raw records for this purpose to one kind of party: a business associate. So a buyer can de-identify them for you.
Get a business associate agreement signed before any chart leaves your systems.
Mercor says it signs an NDA, runs the export, and removes or protects personal information. Its listing says records are de-identified to HIPAA Safe Harbor or Expert Determination.
A limited data set is not de-identified. Under 164.514(e) it’s still protected health information, and it needs a data use agreement, so it’s a weaker basis for a license.
How do you de-identify patient records to HIPAA standards?
Safe Harbor is the checklist route. These are the 18 categories from 164.514(b)(2)(i), for the patient and for relatives, employers and household members:
| Identifier | What the rule says |
|---|---|
| Names | Remove |
| Geography smaller than a state | Remove, except a three-digit ZIP covering more than 20,000 people |
| Dates tied to the patient | Year only, and ages over 89 become “90 or older” |
| Phone and fax numbers | Remove |
| Email addresses, URLs, IP addresses | Remove |
| Social security numbers | Remove |
| Medical record and health plan numbers | Remove |
| Account, certificate and license numbers | Remove |
| Vehicle and device identifiers and serial numbers | Remove |
| Biometric identifiers, including finger and voice prints | Remove |
| Full face photographs and comparable images | Remove |
| Any other unique identifying number, characteristic or code | Remove, unless it’s a re-identification code that meets 164.514(c) |
Those 12 rows cover all 18 lettered items, since dates, phone and fax, and the three online identifiers each count separately in the regulation.
Safe Harbor has a second half that teams forget. Under 164.514(b)(2)(ii) you must also have no actual knowledge that the remaining information could identify a patient.
Free text is where this gets hard. A note that says “seen at our Tuesday clinic with her husband Dave, who works at the mill” carries three identifiers past any structured-field scrubber.
Imaging adds burned-in text. Mercor’s imaging listing asks for studies that can be fully de-identified “including text burned into images,” which means pixel-level checks, not just DICOM tags.
Expert determination is the other route, under 164.514(b)(1). A qualified person applies statistical methods, determines the risk is very small, and documents the methods and results.
Pick expert determination when Safe Harbor would gut the data. Rare-disease cohorts, exact ages and admission dates often matter to the buyer, and only a documented risk analysis can keep them.
164.514(c) lets you keep a re-identification key, as long as the code isn’t derived from patient information and you never disclose the mechanism.
Our guide to anonymizing data for AI training covers the tools and standards in more detail.
What about behavioral health, substance use and state law?
Part 2 applies to records that “would identify a patient as having or having had a substance use disorder,” held by a federally assisted program. That’s 42 CFR 2.12(a)(1).
Mercor lists behavioral health as a practice type it wants, so check whether your program is covered before you scope anything. If it is, treat those charts as a separate pile with separate advice.
State law is the other layer. Washington’s My Health My Data Act, at RCW 19.373.070, requires a signed authorization for the sale of consumer health data.
That authorization is separate from any collection consent, and the seller and buyer each keep a copy for six years.
That act mostly reaches data outside HIPAA, so it hits app and digital health records harder than a covered practice’s charts. California, Texas and others have their own medical information rules.
Ask counsel two questions. Which state laws follow your patients, and does any of them restrict de-identified data as well as identifiable data.
Who buys medical practice data?
- Mercor: de-identified charts with physician notes, for practices with 10+ clinicians or 2,500+ patients. Pays $80,000 to $820,000, through its medical practice listing.
- Mercor, imaging: DICOM studies and raw ECG, EEG or EMG waveforms paired with signed reports, any size practice, $80,000 to $620,000.
- Mercor, digital health: consented visit recordings with transcripts and notes, for companies with 10 to 500 staff, $100,000 to $900,000.
- Segmed: builds de-identified real-world imaging datasets from a partner network of health systems and practices. It publishes no payout terms, so you negotiate blind.
- micro1: operational data only, listed on its data partnerships page as software, finance, support, sales, legal and operations work, for companies with 30 or more full-time staff. Patient records aren’t on its list, but a large group’s back-office records are. You can apply to micro1 here.
Exclusivity is the term to watch. Mercor rules out data already licensed exclusively through a broker, so signing one exclusive deal closes the others off.
Our list of companies that buy business data for AI has each buyer’s terms.
What are the steps for a practice, start to finish?
- Count what you have. Patients, clinicians, years in the EHR, and whether notes are free text or templates.
- Check the export. Ask your EHR vendor what a bulk clinical export includes and costs, and who signs off on it.
- Pick a de-identification route. Safe Harbor if standard fields are enough, expert determination if the buyer needs exact dates or rare cohorts.
- Set aside the restricted piles. Part 2 substance use records, and anything your state treats differently.
- Apply to a buyer. Mercor’s listing scopes the data on a call and asks who handles de-identification today.
- Sign a business associate agreement first. Any buyer touching identifiable charts to de-identify them is a business associate.
- Have counsel review the license. Our AI data licensing agreement checklist lists the clauses to check, including a ban on re-identification.
- Test a sample. Have a clinician read 20 de-identified notes and try to name the patient.
Start with one specialty and one year. It proves the pipeline before you commit the whole archive.
Telehealth apps and other digital health companies face different rules, because many sit outside HIPAA. Our guide to selling digital health data to AI covers them.
Common mistakes when selling medical practice data to AI
The most common mistake is scrubbing structured fields and shipping the notes untouched. These are the others:
- Treating a limited data set as de-identified data
- Forgetting the no-actual-knowledge half of Safe Harbor
- Leaving text burned into images and scanned documents
- Shipping rare-disease cohorts small enough to identify by diagnosis alone
- Letting a buyer touch raw charts with no business associate agreement
- Mixing Part 2 substance use records into the general export
- Signing an exclusive license and losing every other buyer
- Reading Mercor’s $70,000 referral fee as what the practice gets paid
Frequently asked questions
Can a medical practice sell patient data to AI companies?
Yes, once the records are de-identified under 45 CFR 164.514, because de-identified information isn’t protected health information. Selling identifiable records needs a patient authorization that states the disclosure will pay the practice.
How much do AI companies pay for medical practice data?
Mercor’s medical practice listing pays $80,000 to $820,000, depending on patient count and note depth. Imaging centers get $80,000 to $620,000 and digital health companies $100,000 to $900,000.
Does HIPAA allow the sale of de-identified health data?
Yes. Under 164.502(d)(2), information de-identified under 164.514(a) and (b) is not individually identifiable health information, and the Privacy Rule’s requirements don’t apply to it.
What counts as de-identified under HIPAA?
Either Safe Harbor, which removes 18 categories of identifier with no actual knowledge that the rest could identify someone, or expert determination, where a qualified person documents that the re-identification risk is very small.
How many patients does a practice need to sell data to Mercor?
Mercor’s listing takes practices with 10 or more clinicians or 2,500 or more patients, and wants 12 months or more of visits per patient. United States records are preferred.
Do behavioral health records have extra rules?
Yes, if they come from a federally assisted substance use disorder program. 42 CFR Part 2 applies to records that would identify a patient as having a substance use disorder, on top of HIPAA.
Last updated: November 6, 2026
Disclosure: some links on this page are affiliate links. If you sign up through one, we earn a commission at no extra cost to you.
This isn’t legal advice. Have your privacy officer or counsel review any data deal before you sign.






